Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease

Authors not listed

Anavex Life Sciences Corp. · 2016

Abstract

This open label extension study is designed to provide continued access to ANAVEX 2-73 for eligible subjects with mild to moderate Alzheimer's Disease who have previously participated in the Anavex sponsored study ANAVEX2-73-002.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-11 MST

Cite this

APA
Anonymous. (2016). An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease. <em>Anavex Life Sciences Corp.</em>. https://clinicaltrials.gov/study/NCT02756858
Vancouver
Anonymous. An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease. Anavex Life Sciences Corp.. 2016.
BibTeX
@misc{anon2016AnExte, title = {An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease}, author = {Anonymous}, journal = {Anavex Life Sciences Corp.}, year = {2016}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings